SE-driven genes, such as MYC, are particularly upregulated in cancer and are challenging to target directly, but this difficulty might be overcome by targeting CDK7.347–349 Studies in multiple types of cancer support this hypothesis. This evidence concerns the gene CDK7 and cancer.